Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 9.42 USD -7.56% Market Closed
Updated: Jun 2, 2024

Phathom Pharmaceuticals Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Phathom Pharmaceuticals Inc
Other Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Other Liabilities
$10.2m
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Other Liabilities
$25B
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
5%
Bristol-Myers Squibb Co
NYSE:BMY
Other Liabilities
$6.7B
CAGR 3-Years
-4%
CAGR 5-Years
6%
CAGR 10-Years
9%
Pfizer Inc
NYSE:PFE
Other Liabilities
$25.8B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
Other Liabilities
$8.3B
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Other Liabilities
$7.9B
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
6%

See Also

What is Phathom Pharmaceuticals Inc's Other Liabilities?
Other Liabilities
10.2m USD

Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Other Liabilities amounts to 10.2m USD.

What is Phathom Pharmaceuticals Inc's Other Liabilities growth rate?
Other Liabilities CAGR 3Y
21%

Over the last year, the Other Liabilities growth was 18%. The average annual Other Liabilities growth rates for Phathom Pharmaceuticals Inc have been 21% over the past three years .